APOLLO HOSPITALS ENTERPRISE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,015 INR | +0.88% |
|
+3.00% | +5.44% |
| May. 31 | Transcript : Apollo Hospitals Enterprise Limited, Q4 2024 Earnings Call, May 31, 2024 | |
| May. 31 | Apollo Hospitals Enterprise Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 91.72 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.68 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +5.44% | 10.36B | B+ | ||
| -25.47% | 15.13B | B+ | ||
| -1.80% | 11.77B | B | ||
| +3.48% | 11.71B | B+ | ||
| +27.17% | 8.54B | B | ||
| -6.29% | 7.42B | A- | ||
| +6.08% | 6.72B | B- | ||
| +0.89% | 6.02B | D | ||
| -4.31% | 4.28B | - | ||
| +11.12% | 4.21B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- APOLLOHOSP Stock
- Ratings Apollo Hospitals Enterprise Limited
